We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam and Collaborators at MIT Publish new In Vivo Research on Systemic Delivery of RNAi Therapeutics

News   Mar 09, 2009

 
Alnylam and Collaborators at MIT Publish new In Vivo Research on Systemic Delivery of RNAi Therapeutics
 
 
 

RELATED ARTICLES

Tech Behind Bitcoin Could Improve Medications of the Future

News

Researchers have developed a prototype of an app that may potentially prescribe the optimal dose of medicine for the individual patient, as well as prevent counterfeit products.

READ MORE

Lab-on-a-Chip Aids Search for Drugs to Prevent Blood Clots

News

A tiny lab the size of a postage stamp could be the next "big thing" in the search for safer anti-clotting drugs to prevent heart attacks and strokes.

READ MORE

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE